GRCE
Grace Therapeutics
GRCE
GRCE
34 hedge funds and large institutions have $19.7M invested in Grace Therapeutics in 2026 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
4% more call options, than puts
Call options by funds: $326K | Put options by funds: $314K
0.41% less ownership
Funds ownership: 27.97% → 27.56% (-0.41%)
Holders
34
Holding in Top 10
–
Calls
$326K
Puts
$314K
Top Buyers
| 1 | +$2.97M | |
| 2 | +$1.67M | |
| 3 | +$656K | |
| 4 |
Renaissance Technologies
New York
|
+$448K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$359K |
Top Sellers
| 1 | -$3.15M | |
| 2 | -$2.22M | |
| 3 | -$1.77M | |
| 4 |
Morgan Stanley
New York
|
-$82.1K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$48K |
